Last checked at 14 Aug 2014 12:20
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Physiomics Share News (PYC)
PYC Share
Price
PYC Share
News
PYC Share
Chat
PYC Share
Trades8
PYC
Live RNS
PYC Share
Charts
PYC Level 2
Console
PYC Live
Share Price
PYC Broker
Ratings
PYC Directors
Deals
PYC Financial
Diary
PYC
Fundamentals
PYC Short
Positions
PYC
Media
Physiomics Information
Share Price Information for Physiomics (PYC)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1.40
Bid:
1.30
Ask:
1.50
Change:
0.05 (3.70%)
Spread:
0.20 (15.385%)
Open:
1.45
High:
1.45
Low:
1.40
Prev. Close:
1.35
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Physiomics raises £555,000 after shelving BioMoti acquisition
Wed, 21st Sep 2016 10:43
(ShareCast News) - AIM listed Physiomics has called off its BioMoti acquisition after investors instead backed plans to develop its modelling and simulation business with a £555,000 discounted fundraising.Physiomics, which develops software to help drug companies predict and understand cancer drug efficacy from pre-clinical research through to clinical development, has placed 2.22m shares at a price 0.025p per share through broker Hybridian.The new shares will begin trading on AIM on 28 September and increase its total number of shares to over 5.7m, plus another 2.4m deferred shares that are not quoted and have no voting rights.Proceeds of the funds raised will be used to accelerate business development for its modelling and simulation business, in particular the clinical version of its 'virtual tumour' technology, which enables predictions to be made on the outcome of human trials based on pre-clinical and other data.The Oxford-based company said it decided not to buy BioMoti, which had been announced in March, as shareholders were more supportive of the company focusing on growing revenues and becoming profitable in the modelling and simulation business, although it remains open to other acquisitions in the future.Shares in Physiomics were down 16.92% to 0.0270p at 1038 BST.
More News
12 Jun 2014 12:24
Physiomics Shares Surge On Diatech Pharmacogenetics Collaboration
LONDON (Alliance News) - Shares in Physiomics PLC surged Thursday, after it said it has signed a head of terms agreement for a new collaboration with Diatech Pharmacogenetics srl. The Oxford-based systems biology company said that, under the terms of the expected collaboration agreement, th
Read more10 Apr 2014 12:30
UK MIDDAY BRIEFING: Same Problems For M&S, WH Smith
LONDON (Alliance News) - Retailers Marks & Spencer and WH Smith Thursday reported better performances than of late, but still saw their shares decline as analysts worried that they still have a lot to do to fix their long-standing issues.
Marks
10 Apr 2014 10:57
UK WINNERS & LOSERS: M&S, WH Smith Drop Sharply After Early Strength
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday. ------- FTSE 100 - WINNERS ------- Resolution, up 1%. The firm said its insurance and pensions provider Friends Life is scrapping active member
Read more10 Apr 2014 08:02
Physiomics To Show New Validation For Virtual Tumour Platform
LONDON (Alliance News) - Physiomics PLC said Thursday that it will be demonstrating a new validation of its Virtual Tumour Clinical Platform at a workshop in France, with a study that shows the platform can be used to make accurate predictions of clinical outcomes. The Virtual Tumour Clinic
Read more3 Apr 2014 11:17
Physiomics In Talks With Pharmaceutical Companies For VTC Platform
LONDON (Alliance News) - Physiomics PLC said Thursday that it is in discussions with pharmaceutical companies about starting the first project to use its Virtual Tumour Clinical platform to predict outcomes for a new pipeline drug. It will be presenting the first validation of its Virtual T
Read more14 Feb 2014 09:37
Physiomics Pretax Loss Narrows In First Half On Revenues Boost
LONDON (Alliance News) - Physiomics PLC Friday said its pretax loss narrowed in its first half as the company increased its customer base, significantly adding to its revenues. The UK-based biology company said its pretax loss narrowed to GBP214,000 for the six months ended December 31 2013
Read more16 Jan 2014 12:21
Physiomics In Collaboration Deal With University Of Dundee Project
LONDON (Alliance News) - Physiomics PLC Thursday said it had signed a collaboration deal with the University of Dundee to assist it in analysing clinical data with an emphasis on developing new mathematical approaches for drug development. It said its part of the collaboration will be fully
Read more